1. Home
  2. RGP vs EQ Comparison

RGP vs EQ Comparison

Compare RGP & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Resources Connection Inc.

RGP

Resources Connection Inc.

N/A

Current Price

$4.10

Market Cap

149.5M

ML Signal

N/A

Logo Equillium Inc.

EQ

Equillium Inc.

N/A

Current Price

$2.01

Market Cap

140.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RGP
EQ
Founded
1996
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
149.5M
140.1M
IPO Year
2000
2018

Fundamental Metrics

Financial Performance
Metric
RGP
EQ
Price
$4.10
$2.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$7.00
$8.00
AVG Volume (30 Days)
261.1K
385.8K
Earning Date
04-08-2026
05-25-2026
Dividend Yield
6.85%
N/A
EPS Growth
79.14
N/A
EPS
N/A
N/A
Revenue
$452,006,000.00
$41,095,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.06
$0.76
52 Week High
$5.55
$3.54

Technical Indicators

Market Signals
Indicator
RGP
EQ
Relative Strength Index (RSI) 49.57 40.88
Support Level $4.17 $1.97
Resistance Level $4.24 $2.58
Average True Range (ATR) 0.17 0.18
MACD -0.00 -0.02
Stochastic Oscillator 51.75 5.88

Price Performance

Historical Comparison
RGP
EQ

About RGP Resources Connection Inc.

Resources Connection Inc is a professional services firm. Its segments include On-Demand Talent provides businesses with a go-to source for bringing in experts when its needed, serving the office of the CFO; Consulting drives transformation across people, processes and technology across domain areas including finance, technology and digital, risk and compliance and operational performance; Europe & Asia Pacific offers both on-demand and consulting services to clients throughout Europe and Asia Pacific; Outsourced Services; and Sitrick. It derives the majority of revenue from On-Demand Talent segment. Geographically, it operates in United States and internationally.

About EQ Equillium Inc.

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

Share on Social Networks: